Sound Science

Halling, K. C., King, W., Sokolova, I. A., Meyer, R. G., Burkhardt, H. M., Halling, A. C. et al: A Comparison of Cytology and Fluorescence In Situ Hybridization for the Detection of Urothelial Carcinoma. J Urol, 164: 1768, 2000

Sarosdy, M. F., Schellhammer, P., Bokinsky, G., Kahn, P., Chao, R., Yore, L. et al: Clinical Evaluation of a Multi-Target Fluorescent In Situ Hybridization Assay for the Detection of Bladder Cancer. J Urol, 168: 1950, 2002                                                                                        

Sarosdy, M.F., Kahn, P.R., Ziffer, M.D., Love, W.R., Barkin, J., Abara, E. O. et al: Use of a Multitarget Fluorescence In Situ Hybridization Assay to Diagnose Bladder Cancer in Patients With Hematuria. J Urol, 176: 44, 2006                                                          

Soda M, Choi YL, Enomoto M, et al. Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer. Nature. 2007;448:561-567

Horn L, Pao W. EML4-ALK: honing in on a new target in non-small-cell lung cancer. J Clin Oncol. 2009;27:4232-4235 

Shaw AT, Yeap BY, Mino-Kenudson M, et al. Clinical features and outcome of patients with non-small-cell lung cancer who harbor EML4-ALK. J Clin Oncol. 2009;27:4247-4253

Kwak EL, Bang Y-J, Camidge DR, et al. Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer. N Engl J Med. 2010;363:1693-1703

Mino-Kenudson and Mark, Reflex testing for epidermal growth factor receptor mutation and anaplastic lymphoma kinase fluorescence in situ hybridization in non-small cell lung cancer. Arch Pathol Lab Med. Vol 134, May 2011. 655-664 

Choi, et al. Identification of Novel Isoforms of the EML4-ALK Transforming Gene in Non-Small Cell Lung Cancer. Cancer Res. 2008;68(13):4971-6  

Rodig SJ , Mino-Kenudson M , Dacic S , et al. Unique clinicopathologic features characterize ALK-rearranged lung adenocarcinoma in the western population. Clin Cancer Res. 2009;15:5216-5223